OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Bookmark and Share
Published: 19 Jul 2021
Views: 775
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of July 12- 18, 2021.

He highlights the KEYNOTE-522 trial where the addition of pembrolizumab to neoadjuvant chemotherapy has shown an EFS benefit in patients with early triple-negative breast cancer.

Alerts this week cover papers from The Breast, Lancet Oncology and Gut.

You can watch Dr Morgan's previous roundup here.

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer